Literature DB >> 21387146

Use of a local sensitivity analysis to inform study design based on a mechanistic toxicokinetic model for γ-hydroxybutyric acid.

Melanie A Felmlee1, Wojciech Krzyzanski, Bridget L Morse, Marilyn E Morris.   

Abstract

γ-Hydroxybutyric acid (GHB), a drug of abuse, demonstrates complex toxicokinetics with capacity-limited metabolism and active renal reabsorption. The objectives of the present study were to conduct a local sensitivity analysis of a mechanistic model for the active renal reabsorption of GHB and to use the results to inform the design of future studies aimed at developing therapeutic strategies for treating GHB overdoses. A local sensitivity analysis was used to assess the influence of parameter perturbations on model outputs (plasma concentrations and urinary excretion of GHB). Further, a sensitivity index was calculated for each perturbed parameter to assess the specific segments of the time course that are critical to parameter estimation. Model outputs were simulated for rats dosed with 200, 400, 600, and 1,000 mg/kg GHB intravenously and individual parameters were perturbed by two-, five-, and tenfold higher and lower than the nominal value. Model outputs were sensitive to perturbations in clearance and volume parameters. In contrast, model outputs were found to be insensitive to changes in distributional parameters suggesting that additional tissue distribution data is required. Based on the sensitivity analysis the 1,000-mg/kg GHB dose can be eliminated from future studies as the parameters can be adequately estimated from the lower doses. To further validate the use of this model, dose-specific sampling schedules were designed based on model predictions for doses of 600 and 1,500 mg/kg. These sampling schedules were able to adequately capture the inflection point and terminal elimination phase of the plasma concentration-time profiles obtained.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21387146      PMCID: PMC3085705          DOI: 10.1208/s12248-011-9264-y

Source DB:  PubMed          Journal:  AAPS J        ISSN: 1550-7416            Impact factor:   4.009


  29 in total

1.  Sensitivity analysis of pharmacokinetic parameters in one-compartment models.

Authors:  G Wu
Journal:  Pharmacol Res       Date:  2000-04       Impact factor: 7.658

2.  Sensitivity analysis for physiologically based pharmacokinetic models.

Authors:  D M Hetrick; A M Jarabek; C C Travis
Journal:  J Pharmacokinet Biopharm       Date:  1991-02

Review 3.  GHB: an important pharmacologic and clinical update.

Authors:  M S Okun; L A Boothby; R B Bartfield; P L Doering
Journal:  J Pharm Pharm Sci       Date:  2001 May-Aug       Impact factor: 2.327

4.  Dose-dependent pharmacokinetics and hypnotic effects of sodium gamma-hydroxybutyrate in the rat.

Authors:  J T Lettieri; H L Fung
Journal:  J Pharmacol Exp Ther       Date:  1979-01       Impact factor: 4.030

5.  Absorption of sodium gamma-hydroxybutyrate and its prodrug gamma-butyrolactone: relationship between in vitro transport and in vivo absorption.

Authors:  C Arena; H L Fung
Journal:  J Pharm Sci       Date:  1980-03       Impact factor: 3.534

6.  Kinetics of in vivo conversion of gamma-[3H]aminobutyric acid to gamma-[3H]hydroxybutyric acid by rat brain.

Authors:  B I Gold; R H Roth
Journal:  J Neurochem       Date:  1977-05       Impact factor: 5.372

7.  Characterization of the pharmacokinetic and pharmacodynamic interaction between gamma-hydroxybutyrate and ethanol in the rat.

Authors:  Diederik K Van Sassenbroeck; Peter De Paepe; Frans M Belpaire; Walter A Buylaert
Journal:  Toxicol Sci       Date:  2003-04-15       Impact factor: 4.849

8.  Mechanistic toxicokinetic model for gamma-hydroxybutyric acid: inhibition of active renal reabsorption as a potential therapeutic strategy.

Authors:  Melanie A Felmlee; Qi Wang; Dapeng Cui; Samuel A Roiko; Marilyn E Morris
Journal:  AAPS J       Date:  2010-05-12       Impact factor: 4.009

9.  GHB (gamma-hydroxybutyrate) carrier-mediated transport across the blood-brain barrier.

Authors:  Indranil Bhattacharya; Kathleen M K Boje
Journal:  J Pharmacol Exp Ther       Date:  2004-06-01       Impact factor: 4.030

10.  Endogenous gamma-hydroxybutyric acid is in the rat, mouse and human gastrointestinal tract.

Authors:  Luciano Tedeschi; Mauro A M Carai; Giampietro Frison; Donata Favretto; Giancarlo Colombo; Santo Davide Ferrara; Gian Luigi Gessa
Journal:  Life Sci       Date:  2003-04-18       Impact factor: 5.037

View more
  4 in total

1.  γ-Hydroxybutyric Acid (GHB) Pharmacokinetics and Pharmacodynamics: Semi-Mechanistic and Physiologically Relevant PK/PD Model.

Authors:  Rutwij A Dave; Kristin E Follman; Marilyn E Morris
Journal:  AAPS J       Date:  2017-06-26       Impact factor: 4.009

2.  γ-Hydroxybutyrate (GHB)-induced respiratory depression: combined receptor-transporter inhibition therapy for treatment in GHB overdose.

Authors:  Bridget L Morse; Nisha Vijay; Marilyn E Morris
Journal:  Mol Pharmacol       Date:  2012-05-04       Impact factor: 4.436

3.  Semi-mechanistic kidney model incorporating physiologically-relevant fluid reabsorption and transporter-mediated renal reabsorption: pharmacokinetics of γ-hydroxybutyric acid and L-lactate in rats.

Authors:  Rutwij A Dave; Marilyn E Morris
Journal:  J Pharmacokinet Pharmacodyn       Date:  2015-09-04       Impact factor: 2.745

4.  Semiphysiologically Based Pharmacokinetic Model of Leflunomide Disposition in Rheumatoid Arthritis Patients.

Authors:  A M Hopkins; M D Wiese; S M Proudman; C E O'Doherty; Djr Foster; R N Upton
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2015-06-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.